JPRN-jRCTs052180006Completed未知
Clinical research of the left ventricular assist device with post-auricular connector - Clinical research of the left ventricular assist device with post-auricular connector
Sawa Yoshiki0 sites3 target enrollmentStarted: November 1, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 3
Study Overview
Brief Summary
Of the three cases in which the study was performed, one died (no causal relationship to the study device), one was discontinued, and one was completed at 6 months. None of the patients had DL infection, which is considered a major complication of implantable ventricular assisted device.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •1) patient who understands the purpose of the study and consents the entry.
- •2) 20 years old or older.
- •3) patient and his family understand and consent end-of-life care.
- •4) severe heart failure patient who needs heart transplantation but is ineligible for it.
- •5) New York Heart Association Class IIIb and IV end-stage left ventricular failure.
- •6) patient who has undergone maximum optimal medical therapy but has been demonstrated to be refractory to it.
- •7) BSA 1.2-2.3m2
- •8)patient who has a care-giver.
Exclusion Criteria
- •1) J-macs profile 1
- •2) patients who have uncontrollable severe infections.
- •3) the prognosis of other diseases is less than 3 years.
- •4) patients who underwent open chest surgery less than 2 weeks before.
- •5) patients who has contraindication of LVAD implantation due to aortic or ventricular aneurysm, or VSD etc(exclude the cases who can undergo the surgery at the same time).
- •6) patients who has moderate AR (exclude the cases who can undergo the surgery at the same time).
- •7) patients with severe cerebral or phsychological disease who can't control LVAD.
- •8) patients who has a tendency to bleed.
- •9) pregnant or who wants to became pregnant
- •10)cirrhosis (Child C)
- •11) patients who refuse transfusion.
- •12) patients who has an allergy to bovine products.
- •13) patients who are participating other clinical studies which affects this study.
- •14) patients who are considered to be inappropriate
- •to join this study by the researcher.
- •15) Patients who can participate in other clinical trials of DT at the time of registration in this study.
- •16) Patients who are predicted to have difficulty discharging due to right ventricular function and severe heart failure after surgery.
- •17) Patients who have active inflammatory disease with a history of oral administration of steroids more than 1month within 1 year, or with a current use of steroids. Otherwise, patients whose general condition is severely impaired by systemic wasting disease except for heart failure.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Clinical research of the left ventricular assist device with post-auricular connectorsevere heart failureJPRN-UMIN000025211Osaka University hospital6
Not yet recruiting
Not Applicable
Evaluate changes in physical activity levels in the weeks following left ventricular assist device implantatioCardiovascular - Other cardiovascular diseasesChronic heart failureACTRN12614000233628Royal Perth Hospital30
Completed
Not Applicable
Right Ventricular Failure After Implantation of Left Ventricular Assist DevicesHeart FailureNCT01999712Emory University83
Completed
Phase 4
Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)Shock, CardiogenicMyocardial InfarctionNCT00417378Deutsches Herzzentrum Muenchen26
Completed
Phase 2
eft Ventricular Lead Acute Clinical StudyHeart Failure - Cardiac decompensation10019280NL-OMON34649Boston Scientific10